鈣阿爾法酮戊二酸 Calcium Alpha-Ketoglutarate

INT-calcium-alpha-ketoglutarate-001 2 個適應症被研究

C 2

適應症與證據等級

骨骼健康 Bone Health

C 🟠 C 薄弱證據已發布 ⚠️ 中度市場風險

→

老化 Aging

C 🟠 C 薄弱證據已發布 🚨 高市場風險

→

法規與權威立場 (L4)

L4a · US FDA

立場：cautious

calcium alpha-ketoglutarate is legal in the U.S. as a supplement ingredient under the Dietary Supplement Health and Education Act (DSHEA), provided manufacturers follow GMP standards and avoid unverified therapeutic claims

來源 ↗

L4b · EU EFSA

立場：neutral

EFSA has not granted specific authorization for novel food use of calcium alpha-ketoglutarate

來源 ↗

L4c · UK NHS

立場：not_addressed

L4d · TW TFDA / 衛福部

立場：cautious

可供食品使用原料彙整一覽表

來源 ↗

L4e · WHO

立場：not_addressed

市場與行銷 (L10)

L10a · TW Market Channels

Rejuvant Calcium Alpha-Ketoglutarate (Ca-AKG)

L10b · TW Legal Identity (TFDA)

可供食品使用原料彙整一覽表

L10c · TW Community (PTT/Dcard/Mobile01)

Rejuvant 吃了七個月生物年齡降八歲